Qilian International Holding Group is a holding company. Through its subsidiaries, Co. is a pharmaceutical and chemical company based in the People's Republic of China that focuses on the development, manufacture, marketing, and sale of oxytetracycline products, licorice products, traditional Chinese medicine derivatives product, heparin product, sausage casings, and fertilizers. Co.'s products include Gan Di Xin®, Qilian Shan® Licorice Extract, Qilian Shan® Oxytetracycline Tablets, Qilian Shan® Oxytetracycline Active Pharmaceutical Ingredients, Ahan® antibacterial paste, Heparin Sodium Preparation, Xiongguan® Organic Fertilizer, and Xiongguan® Organic-Inorganic Compound Fertilizer. The QLI average annual return since 2021 is shown above.
The Average Annual Return on the QLI average annual return since 2021 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether QLI average annual return since 2021 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the QLI average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|